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Bacteriophages in clinical samples 
can interfere with microbiological 
diagnostic tools
Maryury Brown-Jaque1, Maite Muniesa1 & Ferran Navarro2
Bacteriophages are viruses that infect bacteria, and they are found everywhere their bacterial hosts are 
present, including the human body. To explore the presence of phages in clinical samples, we assessed 
65 clinical samples (blood, ascitic fluid, urine, cerebrospinal fluid, and serum). Infectious tailed phages 
were detected in >45% of ascitic fluid and urine samples. Three examples of phage interference with 
bacterial isolation were observed. Phages prevented the confluent bacterial growth required for an 
antibiogram assay when the inoculum was taken from an agar plate containing lysis plaques, but not 
when taken from a single colony in a phage-free area. In addition, bacteria were isolated directly from 
ascitic fluid, but not after liquid enrichment culture of the same samples, since phage propagation lysed 
the bacteria. Lastly, Gram-negative bacilli observed in a urine sample did not grow on agar plates due to 
the high densities of infectious phages in the sample.
Bacteriophages, also known as phages, are bacterial viruses that infect and multiply using the machinery of the 
host bacteria1. Phages can follow lytic or lysogenic pathways, resulting in different infection outcomes. Virulent 
phages only follow a lytic cycle, which begins with phage attachment to the host cell receptor, followed by injec-
tion of its nucleic acid, replication of the nucleic acid, and synthesis of capsid proteins. Capsid proteins assemble 
with one copy of the nucleic acid to form new viral particles, which are released by causing lysis of the host cell. In 
contrast, following attachment and injection of the nucleic acid into the cell, temperate phages can follow either a 
lytic or lysogenic cycle2. In the lysogenic cycle, the phage inserts its DNA into the chromosome of the bacterium 
and remains in a latent state (prophage) until various external conditions induce the prophage to revert to the 
lytic cycle.
The recognition that phages are abundant and pervasive components of many natural environments, includ-
ing the human body3,4, has stimulated considerable interest in their role in microbial systems, both in regulating 
bacterial population density and diversity5 and in horizontal gene transfer6. In addition, there are diverse opinions 
on the role of phages in the homeostasis of intestinal bacterial flora and other microbiota of the human body3,7. 
Since many of the viruses detected in humans are phages3, their interactions with their cellular hosts are undeni-
able. Moreover, phages can mobilize genetic material by transduction, defined as phage-mediated transfer of bac-
terial DNA between two bacterial cells, and the use of certain antibiotics, such as beta-lactamases or quinolones, 
can favor and even increase genetic transduction by activating the induction of prophages8.
Given their abundance and ubiquity, there is a risk of phages contaminating laboratory cultures of clinical 
samples. Previous studies performed with enteric bacteria9–11, including studies in the area of phage therapy12, 
have indicated that the presence of phages may bias the results of enrichment cultures, where they can propagate 
and subsequently interfere with bacterial isolation and identification.
Some microbiological diagnosis methods applied in clinical samples are based on enriched liquid culture 
media (using standardized culture broths for blood, ascitic fluid, etc.), some of which (e.g. Selenite-F broth, 
Alkaline Peptone Water) also contain selective substances. Liquid enrichment cultures are used to increase sam-
ple volume in order to enhance analytical sensitivity, and the use of selective substances in these liquid enrich-
ment cultures can favor the growth of the target pathogen in samples containing many other microorganisms.
Several molecular approaches based on direct detection of pathogen nucleic acid in the clinical sample have 
also been developed. Although these methods facilitate and accelerate diagnosis of infectious processes, some of 
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them require preliminary steps to enrich the target microorganisms13. Even in molecular approaches to antibiotic 
susceptibility testing or epidemiological studies, it remains essential to culture pathological specimens in order to 
isolate and identify the causative pathogen.
It is clear that liquid enrichment cultures are prone to bias due to differential bacterial growth9,11, and we 
hypothesized that the interference of phages present in samples might potentially be a key factor in skewing 
culture results.
In clinical microbiology practice, it is not unusual to observe lysis spots consistent with phage plaques in the 
confluent bacterial growth on agar plates used for antibiogram assays, or even in the culture plates (Fig. 1). This 
observation formed the rationale for this study and prompted our hypothesis. We asked two research questions: 
i) are phages normally present in sterile human clinical samples? and ii) to what extent may cultured bacteria 
be affected by the presence of phages in the sample? Our results confirmed the presence of phages in urine and 
ascitic samples first analyzed directly and then following enrichment culture. Phage interference with microbio-
logical diagnostic tools was supported by direct evidence.
Results
Occurrence of phages in antibiogram agar plates. To confirm that the lysis spots observed in the 
antibiogram agar plates from urine samples (Fig. 1) were produced by phages, five plates (A to E) were selected 
and a 2 cm2 area of the plate area containing the spots was recovered and resuspended in PBS buffer. Suspensions 
were filtered and chloroform-treated, and then used for spot tests, phage enumeration, and electron microscopy. 
Four plates contained E. coli growth (A-D), while one corresponded to P. aeruginosa (E). E. coli WG5 was used 
as the host for phages in plates A-D and P. aeruginosa, isolated from the same plate and pure-cultured after three 
passages, was used as the host for phages in plate E. The spot test confirmed the presence of infectious phages 
in all five suspensions (Fig. 2.1), and after decimal dilution, lysis plaques were observed in the double agar layer 
(Fig. 2.2). All plates contained phages with Siphoviridae morphology (Fig. 2.3).
Occurrence of phages in clinical samples. To further evaluate the presence of phages in normally sterile 
clinical samples, blood, urine, ascitic fluid, CSF and serum were analyzed. No phages were detected in blood, CSF 
or serum samples either by infectivity assays or electron microscopy. In contrast, 46.1% of urine samples 45.8% of 
ascitic fluid samples carried phages (Table 1, direct samples). In addition to these, phages were recovered from the 
surface of CPS agar plates inoculated with urine samples and from liquid cultures inoculated with ascitic liquids 
(Table 1).
The samples contained phages that infected E. coli WG5 and S. sonnei 866, as revealed using the spot test, or 
phage particles as observed by electron microscopy. Given that a positive spot test could be caused by factors 
other than phages, and that some spot tests showed weak lysis, phages were isolated from the lysis zone, diluted 
and enumerated by the double agar layer method, and those showing lysis plaques were confirmed.
Figure 1. Phages on antibiogram plates. Two examples of antibiogram agar plates showing areas of confluent 
bacterial growth, with spots consistent with phage lysis plaques.
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Not all samples revealed infectious phages on E. coli WG5 and S. sonnei 866, the host strains selected for their 
susceptibility to a wide range of phages14. The E. coli WG5 strain was more sensitive to the phages tested and 
results in Table 1 were obtained with this strain. It cannot be ruled out that the use of other bacterial genera would 
have provided additional results, as shown for phages of Bacteroides in animal sera samples15.
Some samples analyzed directly gave a positive spot test, but phages were not subsequently observed under the 
electron microscope. In these cases, phages were taken from the spot test area where propagation had occurred, 
instead of directly from the sample, and in many instances the number of particles increased to reach the required 
levels (minimum of 107 particles/ml) for microscopic visualization, allowing a positive confirmation. However, a 
few samples with a positive spot test still did not show any viral particles by microscopy of phages recovered from 
the lysis area (Table 1).
Morphological types of phages in the samples. Twenty-five samples showed phages, the most common 
morphological type being Siphoviridae (21). Two (one urine and one ascitic fluid sample) showed Podoviridae 
morphology. A Podoviridae phage from one of the ascitic fluid samples was recovered after propagation in E. coli 
WG5 (Fig. 3A). Two urine samples showed phages with Myoviridae morphology. One of these urine samples 
showed Siphoviridae phages when analyzed directly, but after propagation on E. coli WG5 revealed a second 
Myoviridae phage, which was propagated in WG5 to reach the necessary concentration (Fig. 3B,C).
Interference of phages in bacterial strain recovery. Bacteria were isolated in some of the samples. 
Three blood cultures showed E. coli, Enterobacter cloacae or Staphylococcus epidermidis, respectively. Phages 
were not detected in any blood samples. E. coli was detected in 11 urine samples and Citrobacter koseri and P. 
Figure 2. Occurrence of phages in clinical samples. Lysis plaques obtained from the suspension of 
antibiogram plates of urine cultures. 2.1: Spot tests of suspensions of samples A-D in E. coli WG5 and E in P. 
aeruginosa. PBS control. 2.2: Lysis plaques observed by the double agar layer method in E. coli WG5 in 10−7 and 
10−8 dilutions of the suspension of plate A. 2.3: Electron micrographs of phages from plates (A–E). Bar 100 nm.
Type of sample
Blood (6 samples) Urine (16 samples) Ascitic (26 samples) CSF (7 samples) Serum (10 samples)
Liquid culture Direct Agar plate Direct Liquid culture Direct Direct




0 10 5 16 3 0 0
Presence of 
phage particlesb 0 6 5 11 3 0 0
Positive for both 
techniques — 6 5 11 3 — —
% confirmed 
positive 0 46.1 100 45.8 60.0 0 0
Table 1.  Summary of types of samples analyzed and those testing positive for the presence of phages 
directly from the samples or from the agar plates or the liquid cultures where the samples were inoculated. 
aAnalyzed by spot test and confirmed by the double agar layer method using host strains E. coli WG5. bAnalyzed 
by TEM directly from the samples or recovered from the spot test lysis area.
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aeruginosa in another urine sample. Seven of these samples carried phages, but since no liquid culture was per-
formed, no interference was expected.
However, we did find three examples of phage interference.
The first example corresponds to two ascitic fluid samples, both from the same patient which were processed 
in parallel by inoculation on agar plates and by liquid culture under aerobic and anaerobic conditions. E. coli 
was isolated from agar plates of both samples, but surprisingly, it was not detected after propagation in liquid 
cultures. Suspecting that phages had caused bacterial lysis during propagation in the liquid culture, but not in 
the agar plate, we attempted to detect phages in the samples, on the surface of the agar plate and in the super-
natant of the aerobic and anaerobic liquid cultures. Phages corresponding to the Podoviridae and Siphoviridae 
morphological types were detected in the direct samples and in the corresponding supernatants of the aerobic 
liquid culture. No phages were isolated from the surface of the agar plates, probably because of the low densities 
of phages transferred from the samples. No phages were detected in the supernatant of anaerobic cultures either, 
probably because of the slow growth of the strain or the anaerobic conditions, which did not support good phage 
replication.
The second example of interference was in a urine sample inoculated on chromID™ CPS® Elite plates (CPS 
plates). The confluent area showed lysis plaques consistent with the presence of phages (Fig. 4A). From this, an 
inoculum was taken from a colony close to the inoculation zone (Fig. 4A, arrow 1) to perform an antibiogram 
test. This culture was only 14 hours old and the colonies were small. The resulting antibiogram plate (Fig. 4B) 
showed a very poor growth of colonies, with an apparent confluent lysis. In a second test conducted 18 hours 
later, a single colony far from the inoculation zone (Fig. 4A, arrow 2) was taken from the CPS plate and used to 
inoculate a new plate, which this time yielded growth suitable for the antibiogram test (Fig. 4C). Podoviridae-type 
phages (Fig. 4D) were detected in the original urine sample and were also recovered from the surface of the first 
antibiogram plate (Fig. 4B), but not from the second (Fig. 4C).
A third example of interference was in a urine sample obtained from a patient who had received ciprofloxacin 
and levofloxacin three weeks prior to the infection process, but no subsequent antimicrobial treatment before 
sample collection. The sediment of this urine showed 10–25 white blood cells per high-power field and abun-
dant Gram-negative bacilli were observed by Gram staining (Fig. 5A), suggesting the presence of more than 105 
colony-forming units per milliliter of urine (cfu/mL). Nevertheless, only 14 E. coli colonies grew on the CPS plate 
(1.4.103cfu/mL), which clearly did not correspond to the Gram stain observation. Based on the low cfu counts on 
the CPS plates, this sample would have been considered negative for E. coli were it not for the sediment analysis 
results. One of these colonies was used for the antibiogram agar plate, which revealed lysis plaques consistent 
with phages (Fig. 5B), leading us to suspect that phages in the urine sample had induced lysis of the bacteria when 
inoculated on the CPS plate. To confirm this, the surface of the CPS plate was washed in 3 ml PBS buffer, and the 
suspension was chloroform-treated and observed under the electron microscope. Observations revealed phages 
of Siphoviridae morphology (Fig. 5C) at densities higher than 107 particles/ml of sample (the level required for 
electron microscopy observations), which were probably responsible for lysis of the bacteria growing on the CPS 
plate. Moreover, phages isolated from the CPS agar plate were confirmed as infectious by the spot test on the E. coli 
strain isolated from the CPS plate and pure-cultured after three passages. The phages, isolated further from the 
spot test area, were of the same Siphoviridae morphology.
Discussion
An increasing amount of data on the diversity and abundance of phages in human bodies is becoming available. 
Most work in this field has focused on the digestive tract3,16,17 and on feces, where the first phages were isolated in 
the 20th century18,19, and many studies have recently been reported20–23. Nevertheless, it is also well accepted that 
phages are found in other biomes of the human body; for example, phages, phage DNA, or virus-like particles 
have been described in the skin24 and mouth25. In patients with cystic fibrosis, phages have been reported in the 
respiratory tract26, and higher concentrations of phage DNA are found in blood of cardiovascular disease patients 
than in healthy individuals27.
Phages are known to act as regulators of bacterial populations in the intestinal tract3,28, a role they might also 
play in other biomes within the human or animal body, although knowledge of the true extent of phages could be 
hampered by the inter- and intra-individual heterogeneity of the samples analyzed. It is nevertheless reasonable 
to assume that in the same way than bacteria can translocate from gateways in different parts of the human body, 
Figure 3. Morphological types of phages observed in samples. (A) Podoviridae from an ascitic fluid sample 
after propagation in WG5. (B) Siphoviridae and C: Myoviridae from a urine sample. (B,C) correspond to the 
same urine sample, which when processed directly showed only B and when enriched showed both. Bar 100 nm.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:33000 | DOI: 10.1038/srep33000
Figure 4. Interference of phages in antibiogram plates. (A) ChromID™ CPS® Elite plate of a urine sample; 
(B) antibiogram agar plate inoculated directly from a colony close to the inoculation zone of this urine sample 
(arrow 1 in Fig. 4A); (C) antibiogram from an isolated colony far from the inoculation zone of this urine sample 
(arrow 2 in Fig. 4A). (A,B) show areas of confluent bacterial growth with spots consistent with phage lysis plaques 
but no spots were observed in (C). Bacteriophage of Podoviridae morphology isolated from (A,B). Bar 100 nm.
Figure 5. Interference of phages in bacterial isolation. (A) ChromID™ CPS® Elite plate of a urine sample;  
(B) Gram staining of the urine sediment; (C) antibiogram agar plate inoculated directly from a colony (arrow in 
B); (D) bacteriophage of Siphoviridae morphology isolated from A. Bar 100 nm.
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translocation might occur also with bacteriophages, as suggested a few years ago29. We propose phage translo-
cation as a possible explanation for our observations in the present study. It is also possible that phages translo-
cate alone, without accompanying bacteria, since many samples were found to carry phages without detectable 
bacteria. Phages can also be introduced when a sample is subjected to culture, interfering with microbiological 
diagnosis. This was confirmed to be the case for urine and ascitic fluid samples. CSF samples were expected to 
be negative because translocation should only occur there very rarely. There may be several explanations for the 
negative results obtained for blood and serum samples: i) the high protein content matrix may have disturbed 
microscopy observations and interfered with phage infectivity, even if using the right host strain; ii) phages are 
never present in blood or serum or only rarely; and iii) phage densities may have been too low to be detected 
by the methods used here. Nevertheless, the presence of phages in animal serum samples has been previously 
reported, although rarely15.
The bacteria and phage densities required for phage replication and subsequent destruction of the host cell30,31 
can occur in some clinical samples. In our study, phages were directly observed by electron microscopy in many 
samples, indicating a minimum phage density of 107 particles/ml of sample. Moreover, the physiological state of 
bacteria actively growing in a culture is optimal for phage replication31. Therefore, if the sample contains bacteria 
susceptible to infection by co-present phages, the bacterial densities achieved during enrichment could favor 
phage infection and replication, even when initial numbers are low. During replication, the increasing number 
of phages released by cell lysis can devastate a cultured bacterial population within a few hours, hence preventing 
isolation of the pathogen. This could account for the situation we observed in two ascitic fluid samples: E. coli was 
isolated from agar plates of both samples, but the liquid cultures tested negative for the bacteria, presumably due 
to lysis caused by propagation of the phages observed in the sample by electron microscopy.
Bias in the quantification of bacteria in enrichment cultures is frequently mentioned in the literature. This is 
typically manifested in discrepancies between the bacterial numbers detected by plating on solid medium, where 
phages cannot propagate so efficiently, and the counts obtained by the most probable number (MPN) method in 
liquid medium cultures, with surprisingly higher results obtained in agar plates than for MPN32. This bias cannot 
always be attributed to phages, which are not found in all samples, as shown in our study, and may not necessarily 
be able to propagate. Susceptible host bacteria might not be present, or might not be sufficiently metabolically 
active to allow phage replication. However, the contribution of phages is certainly a factor for consideration.
Phage interference when performing antibiograms has long been observed and documented15, but we noted 
that in some cases, the presence of phages (confirmed by electron microscopy) could even invalidate susceptibility 
studies. Also common in the literature are inconsistent results in microbiological diagnoses of various clinical 
samples (blood cultures, ascitic fluids, CSF, etc.) when a pathogen is detected and / or quantified by molecular 
methods (mostly PCR and qPCR) as opposed to isolation33,34. Possible explanations include prior antibiotic ther-
apy, competition with commensal bacteria in the sample, the pathogen being in a viable but not cultivable state, 
or simply that the target bacteria are present in very low amounts. Based on the present study, a new additional 
factor for consideration is the presence of phages.
One possible scenario is that phages can lyse bacteria, preventing their isolation, although bacterial DNA may 
still be present in the sample. Further implications can occur when using only molecular methods based on the 
detection of a specific gene, or even bacterial 16SrDNA. Phages, and phage-related elements, can cause packaging 
of bacterial DNA and mobilize it6,35–38. The occurrence of free phage particles bearing this gene in a given clini-
cal sample could consequently interfere with the molecular detection of the pathogen, because they could yield 
positive results of the gene detected by PCR without the bacterial pathogen actually being present. An example 
is Shiga toxin phages in enterohemorrhagic E. coli, found in abundance in human fecal samples as free viral par-
ticles in the absence of bacteria21. The DNA extraction methods cannot distinguish between phages and bacteria 
without a proper pretreatment to remove the phages10.
The data presented here indicate that at least some clinical samples carry phages and that these latter can 
bias the outcome of the clinical analysis. We suggest exploring methods for virus removal, such as filtration or 
the application of virucides, to reduce the presence of phages, where suspected, and contribute to more efficient 
recovery of bacterial isolates during microbiological diagnosis.
Methods
Samples. 6 blood, 16 urine, 26 ascitic fluid, 7 cerebrospinal fluid (CSF), and 10 serum samples were collected 
from 65 patients with a potential microbial infectious disease attending the Hospital de la Santa Creu i Sant Pau 
(Barcelona, Spain). All samples were used after performing a conventional microbiological diagnosis and were 
completely anonymized. No data on patients were collected and samples were destroyed immediately after the 
study.
The presence of phages was evaluated, as described below, in liquid cultures of blood; directly or from agar 
plates for urine samples; directly or after liquid culture for ascitic samples; directly for CSF samples; directly for 
serums; and also from antibiogram agar plates (Table 1).
Liquid cultures. Samples were processed according to conventional protocols for isolating pathogenic bacte-
ria39. Using the BacT ⁄ALERT blood culture system (BioMérieux, Marcy l’Etoile, France), an aerobic and an anaer-
obic BacT⁄ALERT blood culture bottle were each inoculated with 5–10 ml of ascitic fluid or blood at the bedside. 
The bottles were placed in the BacT⁄ALERT instrument, incubated for five days, and processed according to the 
manufacturer’s instructions. Each bottle was treated independently. Cultures were not performed with serum 
samples, which only underwent serological testing before being evaluated for the presence of phages.
Bacterial isolation. 25 μ l of ascitic fluid and CSF was inoculated in Columbia agar containing 5% sheep 
blood (BioMérieux), chocolate agar PolyViteX (BioMérieux) and Schaedler agar containing 5% sheep blood 
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(BioMérieux). Cultures were incubated in 5% CO2 (PolyViteX and Columbia agar plates) or in an anaerobic 
atmosphere (Schaedler agar plate) at 35 °C for 2–4 days and examined daily for visible growth. Direct ascitic fluid 
and CSF were also subjected to Gram staining.
ChromID™ CPS® Elite plates (BioMérieux) (CPS) were inoculated with 10 μ l of urine samples, and plates 
were incubated aerobically at 35 °C for 24 hours. All samples previously underwent microscopic urine sediment 
analysis and Gram staining.
Bacteria were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS). Susceptibility studies of microorganisms were performed by disc diffusion antibiotic sus-
ceptibility testing40.
Phage purification. 15 ml of blood liquid cultures, 10 ml of direct urine samples, 0.3–0.5 ml of CSF samples, 
5 ml of either direct ascitic samples or liquid cultures of ascitic samples, and 5 ml of serum samples were used for 
phage purification. The volumes described above were filtered through low protein-binding 0.22-μ m-pore-size 
membrane filters (Millex-GP, Millipore, Bedford, MA). When necessary, several filter units were used to filter the 
whole volume. If the volume was insufficient for filtration (e.g. CSF), it was raised to 2 ml with PBS and filtered. 
Filtered samples were treated with chloroform (1:10), vortexed for 2 min, and centrifuged at 16,000xg for 5 min. 
Initially, the supernatant of five ascitic liquid cultures was processed directly and after 100-fold concentration by 
means of protein concentrators (100 kDa Amicon Ultra centrifugal filter units, Millipore). However, we observed 
that the concentration step broke the phage tails and concentrated any element of a proteic nature in the sam-
ple, which disturbed electron microscopy observations. Therefore, the remaining samples were analyzed without 
concentration.
Infectivity of phages present in the samples. Laboratory strains of E. coli WG5 (ATCC 700078) and a 
clinical isolate Shigella sonnei 86614 were used as hosts for bacteriophage propagation. One isolate of Pseudomonas 
aeruginosa from one antibiogram plate and one E. coli isolate from a CPS agar plate were also used in this study as 
host strains for bacteriophage propagation.
Phage propagation was performed in solid culture (by a spot test or enumeration by the double agar layer 
technique) or liquid culture. For the spot test, 1 ml of target bacteria at OD600 of 0.3 was mixed with Luria Bertrani 
(LB) semi-solid agar (0.7% agar), poured onto LB agar plates, and solidified at room temperature. 20 μ l of phage 
suspension was spotted onto each of the plate surfaces, which were inspected for lysis zones after overnight incu-
bation at 37 °C. Phage enumeration was performed by the double agar layer method as previously described1. 
Liquid cultures were performed using 1 ml of host strain and 1 ml of phage suspension in 8 ml of LB broth and 
incubated overnight at 37 °C while gently shaking.
Phages were recovered from the lysis zones with a loop, suspended in 0.5 ml of PBS buffer, chloroform-treated, 
and used for electron microscopy studies. For phage suspensions obtained from liquid cultures, 2 ml of culture 
was filtered and chloroform-treated as described above.
Electron microscopy studies. 10 μ l of phage suspensions were dropped onto copper grids with 
carbon-coated Formvar films and negatively stained with 2% ammonium molybdate (pH 6.8) for 1.5 min. The 
samples were examined in a Jeol 1010 transmission electron microscope (JEOL Inc. Peabody, MA USA) operating 
at 80 kV.
Ethics. The Ethics Committee of Hospital de la Santa Creu i Sant Pau approved the research (approval num-
ber: 12/065/1350) and waived the need for consent. The samples were anonymized.
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